ZA200201357B - Vaccine against intra-cellular pathogens. - Google Patents

Vaccine against intra-cellular pathogens.

Info

Publication number
ZA200201357B
ZA200201357B ZA200201357A ZA200201357A ZA200201357B ZA 200201357 B ZA200201357 B ZA 200201357B ZA 200201357 A ZA200201357 A ZA 200201357A ZA 200201357 A ZA200201357 A ZA 200201357A ZA 200201357 B ZA200201357 B ZA 200201357B
Authority
ZA
South Africa
Prior art keywords
vaccine against
cellular pathogens
intra
against intra
pathogens
Prior art date
Application number
ZA200201357A
Other languages
English (en)
Inventor
Camilo Anthony Leo Selw Colaco
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Publication of ZA200201357B publication Critical patent/ZA200201357B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
ZA200201357A 1999-08-19 2002-02-18 Vaccine against intra-cellular pathogens. ZA200201357B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9919733.7A GB9919733D0 (en) 1999-08-19 1999-08-19 Vaccines against intracellular pathogens

Publications (1)

Publication Number Publication Date
ZA200201357B true ZA200201357B (en) 2003-07-30

Family

ID=10859500

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200201357A ZA200201357B (en) 1999-08-19 2002-02-18 Vaccine against intra-cellular pathogens.

Country Status (14)

Country Link
EP (1) EP1204421B1 (xx)
JP (1) JP2003527322A (xx)
CN (1) CN1182871C (xx)
AT (1) ATE413887T1 (xx)
AU (1) AU6709700A (xx)
CA (1) CA2382331C (xx)
DE (1) DE60040792D1 (xx)
DK (1) DK1204421T3 (xx)
ES (1) ES2316380T3 (xx)
GB (1) GB9919733D0 (xx)
IL (2) IL148154A0 (xx)
PT (1) PT1204421E (xx)
WO (1) WO2001013943A2 (xx)
ZA (1) ZA200201357B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0910591D0 (en) 2009-06-19 2009-07-29 Immunobiology Ltd Method for the purification of protein complexes
GB0916557D0 (en) * 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB201104897D0 (en) 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0888053A4 (en) * 1995-08-18 2002-07-31 Sloan Kettering Inst Cancer METHOD FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES AND COMPOSITIONS USEFUL FOR THE TREATMENT
US5837251A (en) * 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
JPH11513369A (ja) * 1995-09-13 1999-11-16 フォーダム ユニバーシティー 熱ショックタンパク質を用いる治療及び予防方法
US5985270A (en) * 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US6130087A (en) * 1996-10-07 2000-10-10 Fordham University Methods for generating cytotoxic T cells in vitro
US6017540A (en) * 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US5830464A (en) * 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
GB9818133D0 (en) * 1998-08-19 1998-10-14 Quadrant Holdings Cambridge Vaccine

Also Published As

Publication number Publication date
EP1204421B1 (en) 2008-11-12
WO2001013943A2 (en) 2001-03-01
CA2382331A1 (en) 2001-03-01
JP2003527322A (ja) 2003-09-16
PT1204421E (pt) 2009-03-18
WO2001013943A3 (en) 2001-09-20
DE60040792D1 (de) 2008-12-24
ATE413887T1 (de) 2008-11-15
CN1370077A (zh) 2002-09-18
ES2316380T3 (es) 2009-04-16
EP1204421A2 (en) 2002-05-15
AU6709700A (en) 2001-03-19
CA2382331C (en) 2011-06-14
IL148154A (en) 2008-11-26
GB9919733D0 (en) 1999-10-20
DK1204421T3 (da) 2009-03-09
IL148154A0 (en) 2002-09-12
CN1182871C (zh) 2005-01-05

Similar Documents

Publication Publication Date Title
WO2002034205A3 (en) Using heat shock proteins to increase immune response
WO2005116270A3 (en) Influenza virus vaccine composition and method of use
ATE447967T1 (de) Verpackung von immunstimulierendem cpg in virusähnlichen partikeln: herstellungsverfahren und verwendung
EP1504112A4 (en) DEVELOPMENT OF A VACCINE FOR THE PREVENTION OF INFECTIONS WITH THE FILOVIRUS IN PRIMATES
IL202978A0 (en) West nile virus vaccine
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
GB0123580D0 (en) Vaccine
WO2002036790A3 (en) Influenza virus vector for infection of dendritic cells
EP1471936A4 (en) HIV VACCINE AND METHOD OF USE
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
ZA200201357B (en) Vaccine against intra-cellular pathogens.
GB9818133D0 (en) Vaccine
IL148741A0 (en) Vaccine
WO2001063278A3 (en) Antigenic fragments associated with stress-induced proteins and their use as vaccines
WO2005012538A3 (en) Accelerated vaccination
GB9919734D0 (en) Vaccines from infectious agents
AU2002212555A1 (en) Yeast derived vaccine against ipnv
WO2003054176A3 (en) Preparation of vaccines using photosensitizer and light
WO2002096940A3 (en) Attenuated very virulent infectious bursal disease virus
GB9919732D0 (en) Trehalose producing cells as vaccines